Condition: Metabolic Syndrome X · Fatty Liver · MASH - Metabolic Dysfunction-Associated Steatohepatitis · Sponsor: E-Scopics
The objective of the study is to evaluate an ultraportable ultrasound device, Hepatoscope, for the non-invasive assessment of hepatic steatosis in patients with metabolic-dysfunction associated liver diseases (MASLD), by comparing its measurements with current diagnostic modalities, such as MRI-PDFF.
This description comes directly from the study's public registry record.
Jerome Boursier, MD, PhD · +33 2 41 35 31 42 · jeboursier@chu-angers.fr
Always discuss trial participation with your own doctor first.
| University Hospital Angers | Angers, France | Recruiting |
| Beaujon University Hospital | Clichy, France | Recruiting |
| Pitie Salpetriere University Hospital | Paris, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06661655